JASON SKYLAR SCHREIBER

Allopathic & Osteopathic Physicians|Family Medicine TRAVERSE CITY, MI NPI 1568091874

General Payments — all program years on this page

$536.58

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 29
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $358.27 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $358.2720

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $178.319
2024 $358.2720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086199818 Bayer Healthcare Pharmaceuticals Inc. $13.90 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086254512 Bayer Healthcare Pharmaceuticals Inc. $16.14 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089479639 Daiichi Sankyo Inc. $17.05 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096627382 Novo Nordisk Inc $16.97 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097263949 Novo Nordisk Inc $17.05 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101389438 E.R. Squibb & Sons, L.L.C. $13.65 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105766444 AstraZeneca Pharmaceuticals LP $18.49 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106040982 ABBVIE INC. $29.39 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111700446 Amgen Inc. $24.12 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118839635 Otsuka Pharmaceutical Development & Commercialization, Inc. $25.90 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120633216 Baxter Healthcare $14.26 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130874707 PFIZER INC. $21.30 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131426425 PFIZER INC. $13.43 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135031836 Lilly USA, LLC $15.93 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135053586 Lilly USA, LLC $19.19 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139283264 Astellas Pharma US Inc $16.85 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141911358 Merck Sharp & Dohme LLC $15.17 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144598054 Xeris Pharmaceuticals, Inc. $16.54 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146484146 Antares Pharma, Inc. $17.69 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147294160 Mylan Specialty L.P. $15.25 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.